Prerenal Failure

Overview

Prerenal failure is azotemia caused by poor perfusion of the nephrons. Low perfusion reduces glomerular pressure, which reduces the pressure difference between afferent arterioles and Bowman’s spaces. This ultimately leads to reduced glomerular filtration rate (GFR). Reduced perfusion is sensed by juxtaglomerular cells, which secrete renin to activate the RAAS in an attempt to raise blood pressure. Aldosterone increases overall reabsorption, including sodium, water and blood urea nitrogen (BUN).

PathologyCause
Reduced vascular volumeHaemorrhage, hypovolemia, diarrhoea and vomiting, burns, pancreatitis, hypoaldosteronism (Addison’s disease), third-spacing (hypoalbuminemia)
Reduced cardiac outputCardiogenic shock, myocardial shock
Systemic vasodilationSepsis, drugs
Renal vasoconstrictionNSAIDs, ACE-i, ARBs, hepatorenal syndrome, renal artery stenosis

Renal Artery Stenosis

Renal artery stenosis is narrowing of the renal artery, commonly due to atherosclerotic disease (80%) or bilateral fibromuscular dysplasia in young women.

  • Pathophysiology
    • Low kidney perfusion activates RAAS
    • Increased angiotensin II constricts efferent arteriole and raises blood pressure (hypertension)
    • Increased aldosterone increases intravascular volume and causes hypokalemia
  • Signs and symptoms
    • Often asymptomatic
    • Secondary hypertension in a young patient (< 30)
    • New-onset hypertension in an older patient ( > 55)
    • Unexplained, sudden pulmonary oedema
  • Physical exam
    • Bruit inferior to the posterior costal margin
  • Investigations
    • U/E/Cs
      • Elevated BUN
      • Elevated creatinine
      • Elevated BUN/Cr ratio (> 20:1)
      • Hypokalemia
    • Urinalysis: to exclude intrarenal failure
      • Unremarkable
    • Serum aldosterone:renin ratio: to exclude primary hyperaldosteronism
      • < 20
    • Duplex ultrasound: best initial imaging modality to diagnose renal aretry stenosis
    • CT angiogram or MRA: to confirm renal artery stenosis
  • Treatment
    • ACEi + statin + aspirin in unilateral atherosclerotic etiology
    • ACEi in unilateral fibromuscular dysplasia
    • Stenting in bilateral or refractory stenosis

NSAID induced prerenal falure

NSAIDs can cause prerenal failure in patients with pre-existing renal disease by inhibiting prostaglandin synthesis which leads to constriction of the afferent areterioles and reduced glomerular filtration ratio. NSAIDs are also associated with acute tubular necrosis and acute interstitial nephritis

  • Treatment
    • Discontinue NSAIDs

Dehydration and Systemic Hypotension

Dehydration and Systemic hypotension are the most common causes of acute renal failure. It is easily reveresed by replacing fluid and has a good prognosis. Diagnosis is clinical.

  • Treatment
    • Fluid replacement

Hypoaldosteronism

Hypoaldosteronism causes poor sodium and water reabsorption leading to hypovolemic hyponatremia. It is commonly caused by Addison disease (autoimmune) and Waterhouse-Friderichsen Syndrome (infectious)

  • Patient history
  • Signs and symptoms
    • Weakness
    • Hypotension and syncope
    • Salt craving
    • Hypoglycemia (due to low cortisol)
    • Uremia
  • Investigations
    • U/E/Cs
    • Urinalysis
      • No abnormalities
    • Complete blood count
      • Anaemia
      • Neutropenia
      • Lymphocytosis
    • Plasma renin
      • High
    • Serum aldosterone
      • Low
  • Treatment
    • Prednisone and fludrocortisone

Hepatorenal syndrome

Hepatorenal syndrome is an idiopathic prerenal failure caused by severe liver disease. It presents with a prerenal picture with features of liver failure (hypoalbuminemia, hyperbiliubinemia, prolonged PT). It is a diagnosis of exclusion and is usually diagnosed when there is prerenal azotemia in the setting of liver faillure.

  • Pathophysiology
    • Increased Nitric Oxide production → systemic vasodilation → activation of renal sympathetic nervous system → vasoconstriction of afferent arterials → reduced renal perfusion and glomerular filtration rate → activation of RAAS → vasoconstriction → further decrease in GFR → azotemia
  • Signs and symptoms
    • Jaundice
    • Pruritus
    • Asterixis
    • Ascites
    • Spider angioma
    • Peripheral edema
  • Investigations
    • U/E/Cs
      • Elevated BUN
      • Elevated Cr
      • Elevated BUN/Cr
    • Complete blood count
    • LFTs
      • Hypoalbuminaemia
      • Hyperbilirubinaemia
    • Coagulation panel
      • Prolonged PT
    • Paracentestis and culture of ascitic fluid: to rule out spontaneous bacterial peritonitis
      • Elevated PMNs
      • Positive culture
  • Treatment
    • Vasoconstrictors e.g. terlipressin
    • Human albumin
    • 1500 mL normal saline (improvement excludes hepatorenal syndrome)
    • Ceftriaxons (for SBP, until ascitic culture returns negative)
    • Paracentesis for symptomatic ascites
    • Monitor electrolytes and correct as needed
    • Dialysis if needed
Reference Intervals
Biochemistry
ACTHP: <80 ng/L
ALTP: 5–35 U/L
AlbuminP: 35–50 g/L
AldosteroneP: 100–500 pmol/L
Alk. phosphataseP: 30–130 U/L
α-AmylaseP: 0–180 IU/dL
α-FetoproteinS: <10 kU/L
Angiotensin IIP: 5–35 pmol/L
ADHP: 0.9–4.6 pmol/L
ASTP: 5–35 U/L
BicarbonateP: 24–30 mmol/L
BilirubinP: 3–17 μmol/L
BNPP: <50 ng/L
CRPP: <10 mg/L
CalcitoninP: <0.1 mcg/L
Calcium (ionized)P: 1.0–1.25 mmol/L
Calcium (total)P: 2.12–2.60 mmol/L
ChlorideP: 95–105 mmol/L
CholesterolP: <5.0 mmol/L
VLDLP: 0.128–0.645 mmol/L
LDLP: <2.0 mmol/L
HDLP: 0.9–1.93 mmol/L
Cortisol AMP: 450–700 nmol/L
Cortisol MidnightP: 80–280 nmol/L
CK ♂P: 25–195 U/L
CK ♀P: 25–170 U/L
CreatinineP: 70–100 μmol/L
FerritinP: 12–200 mcg/L
FolateS: 2.1 mcg/L
FSHP: 2–8 U/L ♂; >25 menopause
GGT ♂P: 11–51 U/L
GGT ♀P: 7–33 U/L
Glucose (fasting)P: 3.5–5.5 mmol/L
Growth hormoneP: <20 mu/L
HbA1C (DCCT)B: 4–6%
HbA1C (IFCC)B: 20–42 mmol/mol
Iron ♂S: 14–31 μmol/L
Iron ♀S: 11–30 μmol/L
Lactate (venous)P: 0.6–2.4 mmol/L
Lactate (arterial)P: 0.6–1.8 mmol/L
LDHP: 70–250 U/L
LHP: 3–16 U/L
MagnesiumP: 0.75–1.05 mmol/L
OsmolalityP: 278–305 mosmol/kg
PTHP: 0.8–8.5 pmol/L
PotassiumP: 3.5–5.3 mmol/L
Prolactin ♂P: <450 U/L
Prolactin ♀P: <600 U/L
PSAP: 0–4 mcg/mL
Protein (total)P: 60–80 g/L
Red cell folateB: 0.36–1.44 μmol/L
Renin (erect)P: 2.8–4.5 pmol/mL/h
Renin (recumbent)P: 1.1–2.7 pmol/mL/h
SodiumP: 135–145 mmol/L
TBGP: 7–17 mg/L
TSHP: 0.5–4.2 mU/L
T4P: 70–140 nmol/L
Free T4P: 9–22 pmol/L
TIBCS: 54–75 μmol/L
TriglyceridesP: 0.50–2.3 mmol/L
T3P: 1.2–3.0 nmol/L
Troponin TP: <0.1 mcg/L
Urate ♂P: 210–480 μmol/L
Urate ♀P: 150–390 μmol/L
UreaP: 2.5–6.7 mmol/L
Vitamin B12S: 0.13–0.68 nmol/L
Vitamin DS: 50 nmol/L
Arterial Blood Gases
pH7.35–7.45
PaCO₂4.7–6.0 kPa
PaO₂>10.6 kPa
Base excess±2 mmol/L
Urine
Cortisol (free)<280 nmol/24h
Hydroxyindole acetic acid16–73 μmol/24h
Hydroxymethylmandelic acid16–48 μmol/24h
Metanephrines0.03–0.69 μmol/mmol cr.
Osmolality350–1000 mosmol/kg
17-Oxogenic steroids ♂28–30 μmol/24h
17-Oxogenic steroids ♀21–66 μmol/24h
17-Oxosteroids ♂17–76 μmol/24h
17-Oxosteroids ♀14–59 μmol/24h
Phosphate (inorganic)15–50 mmol/24h
Potassium14–120 mmol/24h
Protein<150 mg/24h
Protein/creatinine ratio<3 mg/mmol
Sodium100–250 mmol/24h
Haematology
WCC4.0–11.0 ×10⁹/L
RBC ♂4.5–6.5 ×10¹²/L
RBC ♀3.9–5.6 ×10¹²/L
Hb ♂130–180 g/L
Hb ♀115–160 g/L
PCV ♂0.4–0.54 L/L
PCV ♀0.37–0.47 L/L
MCV76–96 fL
MCH27–32 pg
MCHC300–360 g/L
RDW11.6–14.6%
Neutrophils2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes1.0–4.5 ×10⁹/L (20–45%)
Eosinophils0.04–0.44 ×10⁹/L (1–6%)
Basophils0–0.10 ×10⁹/L (0–1%)
Monocytes0.2–0.8 ×10⁹/L (2–10%)
Platelets150–400 ×10⁹/L
Reticulocytes0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time10–14 s
APTT35–45 s
Paediatric
Pulse Rate (bpm)
Neonate140–160
Infant <1yr120–140
1–5 years110–130
5–12 years80–120
>12 years70–100
Respiratory Rate (tachypnoea)
0–2 months≥60/min
2–12 months≥50/min
1–5 years≥40/min
>5 years≥30/min
Blood Pressure (mmHg)
Term65/45
1 year75/50
4 years85/60
8 years95/65
10 years100/70
Weight Formulas
3–12 months(a + 9)/2 kg
1–6 years2a + 8 kg
>6 years(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn13–20
1 month11–18
2 months10–15
1–2 years10–13
>2 years11–14
MUAC (6 months–5 years)
Obese>17.5 cm
Normal13.5–17.4 cm
At risk12.5–13.4 cm
Moderate malnutrition11.5–12.4 cm
Severe malnutrition<11.5 cm
Developmental Milestones
Social smile1.5 months
Head control4 months
Sits unsupported7 months
Crawls10 months
Stands unsupported10–12 months
Walks12–13 months
Talks18 months
CSF WBC (/mm³)
Term newborn0–25
>2 weeks0–5
Calculator

Post Discussion

Your email address will not be published. Required fields are marked *